Carotid artery stenting performed with a flow-reversal technique: Improved technical performance

Journal of Neuroradiology

Volumn 40, Issue 1, 2013, Pages 29-37

  Castro Afonso, Luis Henrique de ^a   de Oliveira, Lívia ^a   Pontes Neto, Octávio Marques ^a   Fábio, Soraia Ramos Cabette ^a   Wajnberg, Eduardo ^b   Abud, Daniel Giansante ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Carotid artery stenosis; Carotid artery stenting; Carotid stent; Cerebral protection devices; Flow reversal

Indexed keywords

ADULT; AGED; ARTICLE; BRADYCARDIA; BRAIN EMBOLISM; CAROTID ARTERY STENTING; CAROTID ATHEROSCLEROSIS; CATHETER; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DEATH; ECHOGRAPHY; FEMALE; FLOW REVERSAL TECHNIQUE; FLOW REVERSAL TIME; GENERAL ANESTHESIA; GUIDE WIRE; HEART INFARCTION; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MEDICAL DEVICE; MEDICAL PROCEDURES; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATION DURATION; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; SCORING SYSTEM; SYMPTOM; TERTIARY HEALTH CARE; THERAPY EFFECT; TIME; TRANSIENT ISCHEMIC ATTACK; VASCULAR ACCESS;

AGED; AGED, 80 AND OVER; BLOOD VESSEL PROSTHESIS; CAROTID STENOSIS; EMBOLIC PROTECTION DEVICES; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSTHESIS IMPLANTATION; STENTS; TREATMENT OUTCOME;

EID: 84875085974     PISSN: 01509861     EISSN: 17730406     Source Type: Journal    
DOI: 10.1016/j.neurad.2012.03.001     Document Type: Article

References (39)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123(4):e18-e209.
2. Petty G.W., Brown R.D., Whisnant J.P., Sicks J.D., O'Fallon W.M., Wiebers D.O. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 1999, 30:2513-2516.
3. Sacco R.L., Kargman D.E., Gu Q., Zamanillo M.C. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995, 26:14-20.
4. Fine-Edelstein J.S., Wolf P.A., O'Leary D.H., Poehlman H., Belanger A.J., Kase C.S., et al. Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology 1994, 44:1046-1050.
5. Théron J., Raymond J., Casasco A., Courtheoux F. Percutaneous angioplasty of atherosclerotic and postsurgical stenosis of carotid arteries. Am J Neuroradiol 1987, 8:495-500.
6. Writing Committee Members, Brott T.G., Halperin J.L., Abbara S., Bacharach J.M., Barr J.D., et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology. Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Stroke 2011, 42(8):e420-e463.
7. Coppi G., Moratto R., Silingardi R., Rubino P., Sarropago G., Salemme L., et al. PRIAMUS-proximal flow blockage cerebral protection during carotid stenting: Results from a multicenter Italian registry. J Cardiovasc Surg (Torino) 2005, 46:219-227.
8. Higashida R.T., Popma J.J., Apruzzese P., Zimetbaum P., MAVErIC I., MAVErIC I.I. Evaluation of the medtronic exponent self-expanding carotid stent system with the medtronic guardwire temporary occlusion and aspiration system in the treatment of carotid stenosis: combined from the MAVErIC (Medtronic AVE Self-expanding CaRotid Stent System with distal protection In the treatment of Carotid stenosis) I and MAVErIC II trials. Stroke 2010, 41:e102-e109.
9. Kastrup A., Groschel K., Krapf H., Brehm B.R., Dichgans J., Schulz J.B. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke 2003, 34:813-819.
10. Kastrup A., Gröschel K., Nägele T., Riecker A., Schmidt F., Schnaudigel S., et al. Effects of age and symptom status on silent ischemic lesions after carotid stenting with and without the use of distal filter devices. Am J Neuroradiol 2008, 29:608-612.
11. Massop D., Dave R., Metzger C., Bachinsky W., Solis M., Shah R., et al. Stenting and angioplasty with protection in patients at high-risk for endarterectomy: SAPPHIRE worldwide registry first 2,001 patients. Catheter Cardiovasc Interv 2009, 73:129-136.
12. Safian R.D., Bresnahan J.F., Jaff M.R., Foster M., Bacharach J.M., Maini B., et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol 2006, 47:2384-2389.
13. Silver F.L., Mackey A., Clark W.M., Brooks W., Timaran C.H., Chiu D., et al. Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke 2011, 42:675-680.
14. White C.J., Iyer S.S., Hopkins L.N., Katzen B.T., Russell M.E., BEACH Trial Investigators Carotid stenting with distal protection in high surgical risk patients: The BEACH trial 30 day results. Catheter Cardiovasc Interv 2006, 67:503-512.
15. Asakura F., Kawaguchi K., Sakaida H., Toma N., Matsushima S., Kuraishi K., et al. Diffusion-weighted magnetic resonance imaging in carotid angioplasty and stenting with balloon embolic protection devices. Neuroradiology 2006, 48:100-112.
16. Barbato J.E., Dillavou E., Horowitz M.B., Jovin T.G., Kanal E., David S., et al. A randomized trial of carotid artery stenting with and without cerebral protection. J Vasc Surg 2008, 47:760-765.
17. Vos J.A., van den Berg J.C., Ernst S.M., Suttorp M.J., Overtoom T.T., Mauser H.W., et al. Carotid angioplasty and stent placement: comparison of transcranial Doppler US data and clinical outcome with and without filtering cerebral protection devices in 509 patients. Radiology 2005, 234:493-499.
18. Parodi J.C., La Mura R., Ferreira L.M., Mendez M.V., Cersósimo H., Schönholz C., et al. Initial evaluation of carotid angioplasty and stenting with three different cerebral protection devices. J Vasc Surg 2000, 32:1127-1136.
19. Clair D.G., Hopkins L.N., Mehta M., Kasirajan K., Schermerhorn M., Schönholz C., et al. Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. Catheter Cardiovasc Interv 2011, 77:420-429.
20. North American Symptomatic Carotid Endarterectomy Trial Methods, patient characteristics, and progress. Stroke 1991, 22:711-720.
21. Adami C.A., Scuro A., Spinamano L., Galvagni E., Antoniucci D., Farello G.A., et al. Use of the Parodi anti-embolism system in carotid stenting: Italian trial results. J Endovasc Ther 2002, 9:147-154.
22. Parodi J.C., Ferreira L.M., Sicard G., La Mura R., Fernandez S. Cerebral protection during carotid stenting using flow reversal. J Vasc Surg 2005, 41(3):416-422.
23. Grunwald I.Q., Papanagiotou P., Struffert T., Politi M., Krick C., Romaike B.F., et al. Reversal of flow during carotid artery stenting: Use of the Parodi anti-embolism system. Neuroradiology 2007, 49:237-241.
24. Parodi J.C., Wönholz C., Parodi F.E., Sicard G., Ferreira L.M. Initial 200 cases of carotid artery stenting using a reversal-of-flow cerebral protection device. J Cardiovasc Surg (Torino) 2007, 48:117-124.
25. Rabe K., Sugita J., Gödel H., Sievert H. Flow-reversal device for cerebral protection during carotid artery stenting-acute and long-term results. J Interv Cardiol 2006, 19:55-62.
26. Ohki T., Veith F.J., Grenell S., Lipsitz E.C., Gargiulo N., McKay J., et al. Initial experience with cerebral protection devices to prevent embolization during carotid artery stenting. J Vasc Surg 2002, 36(6):1175-1185.
27. Criado E., Doblas M., Fontcuberta J., Orgaz A., Flores A., Wall L.P., et al. Transcervical carotid stenting with internal carotid artery flow reversal: feasibility and preliminary results. J Vasc Surg 2004, 40(3):476-483.
28. Pipinos I.I., Johanning J.M., Pham C.N., Soundararajan K., Lynch T.G. Transcervical approach with protective flow reversal for carotid angioplasty and stenting. J Endovasc Ther 2005, 12:446-453.
29. Ribo M., Molina C.A., Alvarez B., Rubiera M., Alvarez-Sabin J., Matas M. Transcranial Doppler monitoring of transcervical carotid stenting with flow reversal protection: a novel carotid revascularization technique. Stroke 2006, 37(11):2846-2849.
30. Criado E., Fontcuberta J., Orgaz A., Flores A., Doblas M. Transcervical carotid stenting with carotid artery flow reversal: 3-year follow-up of 103 stents. J Vasc Surg 2007, 46:864-869.
31. Matas M., Alvarez B., Ribo M., Molina C., Maeso J., Alvarez-Sabin J. Transcervical carotid stenting with flow reversal protection: experience in high-risk patients. J Vasc Surg 2007, 46:49-54.
32. Alvarez B., Ribo M., Maeso J., Quintana M., Alvarez-Sabin J., Matas M. Transcervical carotid stenting with flow reversal is safe in octogenarians: a preliminary safety study. J Vasc Surg 2008, 47:96-100.
33. Faraglia V., Palombo G., Stella N., Rizzo L., Taurino M., Bozzao A. Cerebral embolization during transcervical carotid stenting with flow reversal: a diffusion-weighted magnetic resonance study. Ann Vasc Surg 2009, 23(4):429-435.
34. Pinter L., Ribo M., Loh C., Lane B., Roberts T., Chou T.M., et al. Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF Study. J Vasc Surg 2011, 54(5):1317-1323.
35. Leal J.I., Orgaz A., Fontcuberta J., Flores A., Doblas M., Garcia-Benassi J.M., et al. A prospective evaluation of cerebral infarction following transcervical carotid stenting with carotid flow reversal. Eur J Vasc Endovasc Surg 2010, 39(6):661-666.
36. Kelso R., Clair D.G. Flow reversal for cerebral protection in carotid artery stenting: a review. Perspect Vasc Surg Endovasc Ther. 2008, 20(3):282-290.
37. Fang H.Y., Chung S.Y., Sun C.K., Youssef A.A., Bhasin A., Tsai T.H., et al. Transradial and transbrachial arterial approach for simultaneous carotid angiographic examination and stenting using catheter looping and retrograde engagement technique. Ann Vasc Surg 2010, 24(5):670-679.
38. Pipinos I.I., Pisimisis G.T., Burjonrappa S.C., Johanning J.M., Longo G.M., Lynch T.G., et al. One patent intracranial collateral predicts tolerance of flow reversal during carotid angioplasty and stenting. Ann Vasc Surg 2009, 23:32-38.
39. Criado E., Doblas M., Fontcuberta J., Orgaz A., Flores A., Lopez P., et al. Carotid angioplasty with internal carotid artery flow reversal is well tolerated in the awake patient. J Vasc Surg 2004, 40(1):92-97.